A high level of cholesterol is associated with obesity, cardiovascular diseases and atherosclerosis. Immune response in atherosclerosis is mediated by chemokines which attract monocytes, leading to the innate immune response characterised by the production of cytokines. The immunoregulatory cytokines are an important bridge between innate and adductive immunity. TH1 cytokines are involved as effector T cells in inflammatory response, while TH2 cytokines can be anti-inflammatory such as IL-10 and IL-4. It is well known that statins enhance the production of TH2 cytokines whereas the secretion of TH1 cytokines is suppressed. For this purpose, we studied the significance of anti-inflammatory effect and suppression of inflammation by statins. In this paper we revisited the role of cholesterol and cytokines IL-18, IL-10, IL-12, TNF-α, interferon-γ, and chemokines in inflammatory diseases.
RobertsonALHanssonGK. T cells in atherogenesis: for better or for worse?Arterioscler Thromb Vasc Biol2006; 26:2421–32.
2.
TedguiAMallatZ. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev2006; 86:515–81.
3.
PalinskiWMillerEWitztumJI. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA1995; 92:821–25.
4.
RichardsonVJ. Divergent and synergistic regulation of matrix metalloprotease production by cytokines in combination with C-C chemokines. Int J Immunopathol Pharmacol2010; 23:715–26.
5.
LiQKobayashiMInagakiH. A day trip to a forest park increases human natural killer activity and the expression of anti-cancer proteins in male subjects. J Biol Regul Homeost Agents2010; 24: 157–65.
6.
SymeonidouIKourelisAFrydasIKaragouniEAnogeianakiAHatzistilianouMFrydasS. Modulation of NF-K.B signalling pathways by parasites. J Biol Regul Homeost Agents2010; 24: 471–79.
7.
SkurkTKolbHMuller-ScholzeSRohrigKHaunerHHerderC. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol2005; 152:863–68.
8.
ThorandBKolbHBaumertJKoenigWChamblessLMeisingerC. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984–2002. Diabetes2005; 54:2932–38.
9.
HungJMcQuillanBMChapmanCMThompsonPLBeilbyJP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol2005; 25:1268–73.
10.
ProfumoEButtariBAlessandriCContiFCapoanoRValesiniGSalvatiBRiganòR. Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques. Int J Immunopathol Pharmacol2010; 23: 73–80.
11.
ZicariAMTancrediGRugianoAZappalàDMidullaFIndinnimeoLDe CastroGCelaniCDuseM. An infant with diaphragmatic eventration and respiratory distress. J Biol Regul Homeost Agents2010; 24:481–84.
12.
AngeliniADi IlioCCastellaniMLContiPCuccurulloF. Modulation of multidrug resistant P-glycoprotein activity by flavonoids and honokiol in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents2010; 24:197–205.
13.
Hossein-NezhadAMirzaeiKBirami JamalFMirfakhraeiRSedighiN. Variation in the COX-2 gene may modify the effect of alendronate on vertebral fracture prevention. Eur J Inflamm2010; 8: 143–49.
14.
ChapmanCMMcQuillanBMBeilbyJPThompsonPLHungJ. Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population: the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Atherosclerosis2006; 189:414–19.
15.
ZirlikAAbdullahSMGerdesNMacfarlaneLSchonbeckUKheraA. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol2007.
16.
CorsaroAAnselmiCPolanoMAcetoAFlorioTDe NobiliM. The interaction of humic substances with the human prion protein fragment 90–231 affects its protease K resistance and cell internalization. J Biol Regul Homeost Agents2010; 24:27–39.
17.
PreethaSPDevarajH. Role of sulphated polysaccharides from Sargassum wightii in the control of diet-induced hyperlipidemia and associated inflammatory complications in rats. Eur J Inflamm2010; 8:23–30.
18.
BlankenbergSTiretLBickelCPeetzDCambienFMeyerJ. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation2002; 106:24–30.
19.
BlankenbergSLucGDucimetierePArveilerDFerrieresJAmouyelP. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation2003; 108:2453–59.
20.
SharmaJN. Activation of the bradykinin system by angiotensin-converting enzyme inhibitors. Eur J Inflamm2010; 8:55–61.
21.
MalerbaMRadaeliAMancusoSPolosaR. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease. J Biol Regul Homeost Agents2010; 24:123–30.
22.
BoringLGoslingJClearyMCharoIF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (Lond)1998; 394:894–97.
23.
GuLOkadaYClintonSKGerardCSukhovaGKLibbyP. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell1998; 2:275–81.
24.
AmorinoGPHooverRL. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol1998; 152:199–207.
25.
ZhangQLNiuQNiuPYJiXLZhangCWangL. Novel interventions targeting on apoptosis and necrosis induced by aluminum chloride in neuroblastoma cells. J Biol Regul Homeost Agents2010; 24:137–48.
26.
Shaik-DasthagirisahebYBCastellaniMLTripodiD. PGD2, IL-1-family members and mast cells. Eur J Inflamm2010; 8:137–42.
27.
RajavashisthTBAndalibiATerritoMC. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature (Lond)1990; 344:254–57.
28.
ClintonSKUnderwoodRHayesLShermanMLKufeDWLibbyP. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol1992; 140:301–16.
29.
MazzoccoliGDe CataAGrecoACarughiSGiulianiFTarquiniR. Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine system. J Biol Regul Homeost Agents2010; 24:341–50.
30.
ShekhawatNVijayvergiaR. Investigation of anti-inflammatory, analgesic and antipyretic properties of Madhuca indica Gmel. Eur J Inflamm2010; 8:165–71.
31.
MachFSautyAIarossiASSukhovaGKNeoteKLibbyP. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest1999; 104: 1041–50.
32.
StemmeSFaberBHolmJWiklundOWitztumJLHanssonGK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA1995; 92:3893–97.
33.
RobertsonAKHanssonGK. T cells in atherogenesis: for better or for worse?Arterioscler Thromb Vasc Biol2006; 26:2421–32.
34.
MagniPRuscicaMDozioEPassafaroLStefaniLMorelliPBanfiGCorsiMM. Plasma adiponectin and leptin concentrations in professional rugby players. J Biol Regul Homeost Agents2010; 24:87–91.
OkamotoYKiharaSFunahashiTMatsuzawaYLibbyP. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond)2006; 110: 267–78.
37.
FantuzziGMazzoneT. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol2007; 27:996–1003.
38.
BorrelliILoffredoSStaianoRIFrattiniABergamaschiAMaroneGTriggianiM. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils. Int J Immunopathol Pharmacol2010; 23:737–44.
39.
GarzaroMPecorariGNadalinJRaimondoLPalmoABaccegaMGiordanoC. Objective and subjective assessment of digestion after ingestion of an iced dessert in healthy volunteers. J Biol Regul Homeost Agents2010; 24:215–20.
40.
AmantiAPotalivoGPelosiFRendeRCerulliG. Randomized prospective study on the use of Eufiss in the prevention of infections in patients treated with external fixation. Eur J Inflamm2010; 8:189–92.
41.
RainesEWFerriN. Thematic review series: the immune system and atherogenesis, cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res2005; 46:1081–92.
42.
MasonDPKenagyRDHasenstabD. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res1999; 85:1179–85.
43.
PalumboPMelchiorreELa TorreC. Effects of phosphatidylcholine and sodium deoxycholate on human primary adipocytes and fresh human adipose tissue. Int J Immunopathol Pharmacol2010; 23:481–89.
44.
CianciRPagliariDPietroniVLandolfiRPandolfiF. Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. J Biol Regul Homeost Agents2010; 24:239–29.
45.
GerdesNSukhovaGKLibbyPReynoldsRSYoungJLSchonbeckU. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med2002; 195:45–257.
46.
MiglioreAPadalinoCMassafraU. Intraarticular injections of infliximab in the treatment of inflammatory rheumatic diseases: case reports and review of literature. Eur J Inflamm2010; 8:49–54.
47.
GenoveseTMelaniAEspositoE. Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. J Biol Regul Homeost Agents2010; 24:73–86.
48.
YanagitaniNShimizuYKazamaTDobashiKIshizukaTMoriM. Eosinophilic bronchiolitis indicating eosinophilic airway disease with overexpression of carcinoembryonic antigen in sinus and bronchiole: case report. J Biol Regul Homeost Agents2010; 24:99–102.
49.
OkamuraHTsutsiHKomatsuT. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature (Lond)1995; 378:88–91.
GiucaMRGiuggioliEMetelliMRPasiniMIezziGD'ErcoleSTripodiD. Effects of cigarette smoke on salivary superoxide dismutase and glutathione peroxidase activity. J Biol Regul Homeost Agents2010; 24:359–66.
52.
SirotkinAVChrenekPPivkoJBalaziAMakarevichAV. Phosphodiesterase inhibitor 3-isobutyl-1-methyl-xanthine affects ovarian morphology and stimulates reproduction in rabbits. Eur J Inflamm2010; 8:173–79.
53.
CalabròPRieglerLLimongelliG. Production of serum amyloid A in response to inflammatory cytokines by human adipocytes. Eur J Inflamm2010; 8:99–105.
54.
LuccheseASerpicoRGuidaACrincoliVScullyCKanducD. Interkeratin peptide-protein interactions that promote HPV16 E7 gene expression. Int J Immunopathol Pharmacol2010; 23:857–64.
55.
FernandezTDTorresMJLopezSAntunezCGomezEDel PradoMFCantoGBlancaMMayorgaC. Role of effector cells (CCR7-CD27-) and effector-memory cells (CCR7-CD27+) in drug-induced maculopapular exanthema. Int J Immunopathol Pharmacol2010; 23:437–47.
56.
PolliceRBianchiniVContiCMMazzaMRonconeRCasacchiaM. Cognitive impairment and perceived stress in schizophrenic inpatients with post-traumatic stress disorder. Eur J Inflamm2010; 8:211–19.
57.
UrsiniFSuccurroEGrembialeARudiSGrembialeRDArturiF. Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab. Int J Immunopathol Pharmacol2010; 23:961–63.
58.
LibbyPAikawaM. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med2002; 8:1257–62.
59.
ChiavaroliABrunettiLOrlandoGRecinellaLFerranteCLeoneSDi MichelePDi NisioCVaccaM. Resveratrol inhibits isoprostane production in young and aged rat brain. J Biol Regul Homeost Agents2010; 24:441–46.
60.
SanciniACaciariTAndreozziG. Respiratory parameters in traffic policemen exposed to urban pollution. Eur J Inflamm2010; 8:157–63.
61.
GallieraELocatiMMantovaniACorsiMM. Chemokine system: new inflammatory markers on the horizon. Eur J Inflamm2010; 8:1–6.
62.
SkalenKGustafssonMRydbergEKHultenLMWiklundOInnerarityTL. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature (Lond)2002; 417:750–54.
63.
MarcheseEVignatiAAlbaneseANucciCGSabatinoGTirpakovaBLofreseGZelanoGMairaG. Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms. J Biol Regul Homeost Agents2010; 24:185–95.
64.
GuerrantiRBertocciEFioravantiAPapakostasPMontellaAGuidelliGMCortelazzoANutiRGiordanoN. Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms. Int J Immunopathol Pharmacol2010; 23:901–9.
65.
MazzoccoliGPazienzaVPiepoliAMuscarellaLAIngleseMDe CataAGiulianiFTarquiniR. Hypothalamus-hypophysis-thyroid axis function in healthy aging. J Biol Regul Homeost Agents2010; 24:433–39.
66.
KruthHS. Sequestration of aggregated low-density lipoproteins by macrophages. Curr Opin Lipidol2002; 13:483–88.
67.
WilliamsKJTabasI. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol1998; 9:471–74.
68.
TarozziAMerliccoAMorroniFBolondiCDi IorioPCiccarelliRRomanoSGiulianiPHreliaP. Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by amyloid-β peptide oligomers. J Biol Regul Homeost Agents2010; 24:297–306.
69.
MarottaFNaitoYBishierMPJainSYadavHMinelliEKumariASolimeneUSollanoJ. Subclinical candiduria in patients with gastrointestinal malignancies: a preliminary study on the protective effect of a natural phytocompound. J Biol Regul Homeost Agents2010; 24:317–24.
70.
NeriGCitraroLMartinottiSToniatoECastriottaADe RosaMFilograna PignatelliG. The role of atypical microorganisms in chronic oropharyngeal phlogosis. Eur J Inflamm2010; 8:201–10.
71.
MillerYIChangMKBinderCJShawPXWitztumJL. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol2003; 14:437–45.
72.
TatoneCCarboneMCCampanellaGFestucciaCArtiniPGTalesaVFocarelliRAmicarelliF. Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation end-products in ovaries of reproductively-aged mice. J Biol Regul Homeost Agents2010; 24: 63–72.
73.
RiccioniGBucciarelliVScottiLAcetoAD'OrazioNDi IlioEBucciarelliT. Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis. J Biol Regul Homeost Agents2010; 24:351–58.
74.
Hossein-NezhadAKhoshniat NikooMMirzaeiKMokhtareiFAghaei MeybodiHR. Comparison of the bone turn-over markers in patients with multiple sclerosis and healthy control subjects. Eur J Inflamm2010; 8:67–73.
75.
Sadeghi KoupaeiMTAhangariGSamanguieiSh. Inflammatory mediator serotonin receptor gene (5-HTR3A) expression changes on human peripheral blood lymphocytes in rheumatoid arthritis. Eur J Inflamm2010; 8:83–88.
76.
CybulskyMIGimbroneMAJr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Wash DC)1991; 251:788–91.
SchiavoniGDi PietroMRoncoCde CalMCazzavillanSRassuMNicolettiMdel PianoMSessaR. Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients. J Biol Regul Homeost Agents2010; 24: 367–75.
79.
GarzaroMRaimondoLNadalinJPecorariGGiordanoC. Subjective assessment of palatability, digestibility and emotions in healthy volunteers after ingestion of an iced dessert: preliminary report. J Biol Regul Homeost Agents2010; 24:391–395.
80.
LiHCybulskyMIGimbroneMAJrLibbyP. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb1993; 13:197–204.
81.
BocchinoMMatareseABellofioreBGiacomelliPRussoASignorielloGGalatiDSanduzziA. Usefulness of IFN-gamma release assays in clinical management of difficult TB cases:evidence from clinical practice. Eur J Inflamm2010; 8:43–47.
82.
CastellaniMLAnogeianakiAToniatoE. Inter-relationship between chemokines and mast cells. Eur J Inflamm2010; 8:7–14.
83.
Miraglia Del GiudiceMPedullàMBruneseFPCapristoAFCapristoCToscaMACiprandiG. Neutrophilic cells in sputum of allergic asthmatic children. Eur J Inflamm2010; 8:151–56.
84.
KohnoMYasunariKMurakawaKYokokawaKHorioTFukuiTTakedaT. Plasma immunoreactive endothelin in essential hypertension. Am J Med1990; 88:614–18.
85.
FerriCBelliniCDesideriGMazzocchiCDe SiatiLSantucciA. Elevated plasma and urinary endothelin-I levels in human salt-sensitive hypertension. Clin Sci (Lond)1997; 93:35–41.
86.
GasbarriniGZacconeVCovinoMGalloA. Effectiveness of a “cold dessert”, with or without the addition of a mixture of digestive herbs, in subjects with “functional dyspepsia”. J Biol Regul Homeost Agents2010; 24:93–98.
87.
NiedworokEMuc-WierzgońMNowakowska-ZajdelE. Influence of magnesium on fatty acids and their esters in isolated rat hepatocytes. J Biol Regul Homeost Agents2010; 24:377–80.
88.
AntonucciADi GiampaoloLZhangQLSicilianoECipolla D'AbruzzoCNiuQBoscoloP. Safety in construction yards: perception of occupational risk by Italian building workers. Eur J Inflamm2010; 8: 107–15.
89.
PedramARazandiMHuRMLevinER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion, J Biol Chem1997; 272:17097–103.
90.
VogelTWoltersHHHölzenJSchmidtHHAugustCDahrenmöllerCSenningerNBrockmannJG. Rituximab rescue therapy for refractory early acute rejection after liver transplantation. Eur J Inflamm2010; 8:125–29.
91.
CastellaniMLDe LutiisMAToniatoE. Impact of RANTES, MCP-1 and IL-8 in mast cells. J Biol Regul Homeost Agents2010; 24:1–6.
92.
SagginiRCavezzaTDi PancrazioLPisciellaVSaladinoGZuccaroMCBellomoRG. Treatment of lesions of the rotator cuff. J Biol Regul Homeost Agents2010; 24:453–59.
93.
GoronzyJJWeyandCM. Immunosuppression in atherosclerosis: mobilizing the opposition within. Circulation2006; 114:1901–4.
94.
HanssonGKLibbyP. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol2006; 6:508–19.
95.
TedguiAMallatZ. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev2006; 86:515–81.
96.
MallatZAit-OufellaHTedguiA. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol2005; 16:518–24.
97.
AlbertMLPearceSFFranciscoLM. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med1998; 188: 1359–68.
98.
WeinerHL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect2001; 3:947–54.
99.
GreenEAGorelikLMcGregorCM. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA2003; 100:10878–83.
100.
ChenMLPittetMJGorelikL. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA2005; 102:419–24.
101.
StachowiczMMazurekUNowakowska-ZajdelENiedworokEFatygaEMuc-WierzgońM. Leptin and its receptors in obese patients with colorectal cancer. J Biol Regul Homeost Agents2010; 24:287–95.
102.
MullolJCallejasFBMéndez-ArancibiaEFuentesMAlobidIMartínez-AntónAValeroAPicadoCRoca-FerrerJ. Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival. J Biol Regul Homeost Agents2010; 24:403–11.
103.
CiprandiGDe AmiciMToscaMAMarsegliaG. Immunoglobulin production pattern in allergic and non-allergic subjects. Eur J Inflamm2010; 8:193–99.
104.
BelghithMBluestoneJABarriotS. TGF- beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med2003; 9:1202–8.
105.
RandelliPRandelliFCabitzaPVaientiL. The effects of COX-2 anti-inflammatory drugs on soft tissue healing: a review of the literature. J Biol Regul Homeost Agents2010; 24:107–14.
106.
SinghSSYadavSKHaldarC. Effect of glucocorticoid and melatonin on immune function of an Indian tropical bird, Perdicula Asiatica: an in vivo and in vitro study. Eur J Inflamm2010; 8:89–97.
107.
BogdanCVodovotzYNathanC. Macrophage deactivation by interleukin-10. J Exp Med1991; 174: 1549–55.
108.
TedguiAMallatZ. Anti-inflammatory mechanisms in the vascular wall. Circ Res2001; 88:877–87.
109.
GrunigGCorryDBLeachMW. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med1997; 185:1089–99.
110.
MiyamotoKMiyakeSYamamuraT. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature2001; 413:531–34.
111.
MinellaDBiancolellaMTestaBProsperiniGZenobiRNovelliGGigantiMG. Androgen- and insulin-related gene signature using a specific low density oligoarray “AndroChip 2” in peripheral blood mononuclear cells in agonists, recreational athletes and sedentary subjects. J Biol Regul Homeost Agents2010; 24:413–23.
112.
ChmielewskaJSzczepankiewiczDSkrzypskiMKregielskaDStrowskiMZNowakKW. Ghrelin but not obestatin regulates insulin secretion from INSI beta cell line via UCP2-dependent mechanism. J Biol Regul Homeost Agents2010; 24:397–402.
113.
GelardiMCassanoMCassanoP. Survival time of nasal mucous membrane ciliated cells: a preliminary study of cytological examination by phase-contrast microscopy. Eur J Inflamm2010; 8: 37–41.
114.
HongSWilsonMTSerizawaI. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in nonobese diabetic mice. Nat Med2001; 7:1052–56.
115.
NakaiYIwabuchiKFujiiS. Natural killer T cells accelerate atherogenesis in mice. Blood2004; 104:2051–59.
116.
AslanianAMChapmanHACharoIF. Transient role for CD Id-restricted natural killer T cells in the formation of atherosclerotic lesions. Arterioscler Thromb Vasc Biol2005; 25:628–32.
117.
VanderLaanPReardonCASagivY. Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am J Pathol2007; 170:1100–07.
118.
NakashimaYRainesEWPlumpASBreslowJLRossR. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol1998; 18:842–51.
119.
SuCPicardPRathboneMPJiangS. Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression. J Biol Regul Homeost Agents2010; 24:19–25.
120.
ZhangG-HLiuY-FHuH-Y. Preparation and cytotoxicity effect of anti-hepatocellular carcinoma SCFV immunoliposome on hepatocarcinoma cell in vitro. Eur J Inflamm2010; 8:75–82.
121.
SanciniATomeiFSchifanoMP. Stress characteristics in different work conditions: is it possible to identify specificity of risk factors by the questionnaire method?Eur J Inflamm2010; 8:117–23.
122.
NieQFanJHaraokaSShimokamaTWatanabeT. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats: implications of the ICAM-1 and LFA-1 pathway in atherogenesis. Lab Invest1997; 77: 469–82.
123.
ShihPTBrennanMLVoraDK. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res1999; 84:345–51.
124.
WeberCErlWWeberKSWeberPC. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol1997; 30: 1212–17.
125.
VaughanCJGottoAMJrBassonCT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol2000; 35:1–10.
126.
StalkerTJLeferAMScaliaR. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol2001; 133:406–12.
127.
RidkerPMRifaiNClearfieldM. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med2001; 344:1959–65.
128.
WenkeKMeiserBThieryJ. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation1997; 96:1398–402.
129.
YoussefSStuveOPatarroyoJC. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature2002; 420:78–84.
130.
KureishiYLuoZShoijimaI. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med2000; 6: 1004–10.
131.
PetruzziMGrassiFRNardiGMMartinelliDSerpicoRLugliePFBaldoniE. Sodium iodide associated to salicylic acid topical management of chronic oral candidiasis: a randomized trial. J Biol Regul Homeost Agents2010; 24:381–84.
132.
GiganteACappellaMManzottiSCecconiSGrecoFDi PrimioRMattioli-BelmonteM. Osteoinduction properties of different growth factors on cells from non-union patients: in vitro study for clinical application. J Biol Regul Homeost Agents2010; 24:51–62.
133.
TrikaliotisCSoulountsiVTsorliniHKatsifaHChatzidimitriouDTrikaliotisKKalaitzopoulouPBitzianiMChatzopouloyFArvanitidouM. Epidemiological study and classification of ICU infections, using the carrier state criterion. Eur J Inflamm2010; 8:181–88.
134.
FeronODessyCDesagerJBalligandJ. Hydroxy-methylglutarylcoenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation2001; 103:113–18.
135.
VergnaniLHatrikSRicciFPassaroAManzoliNZulianiG. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of 1 arginine availability. Circulation2000; 101:1261–66.
136.
NahrendorfMHuKHillerK-H. Impact of hydroxymethylglutaryl conenzyme A reductase inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol2002; 40: 1695–700.
137.
VatrellaAMontagnaniSCalabreseCParrellaRPelaiaGBiscioneGLCorcioneNMarsicoSAGuerraG. Neuropeptide expression in the airways of COPD patients and smokers with normal lung function. J Biol Regul Homeost Agents2010; 24: 425–32.
138.
PapakonstantinouPTzirisNKapoukranidouDGotzamani-PsarrakouATsonidisCHRPatsikasMNPapazoglouG. The effect of porcine Orexin A on glucose-dependent insulinotropic polypeptide plasma concentrations in pigs. Eur J Inflamm2010; 8:15–21.
139.
VrtovsnikFCouetteSPrieDLallemandDFriedlanderG. Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway. Kidney Int1997; 52:1016–27.
140.
RaffaelliLScaramuzzoLRossi IommettiPGraciCMaccauroGManiconePF. Jaw osteonecrosis related to bisphosphonate for bone metastasis. J Biol Regul Homeost Agents2010; 24:115–21.
141.
CiprandiGFenoglioDFerreraFDe AmiciMMarsegliaG. ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy. Eur J Inflamm2010; 8:31–35.
142.
ReissenRAxelDFenchelMHerzogURossmannHKarschK. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Basic Res Cardiol1999; 94:322–32.
143.
EspositoGRossiFPucaAAlbaneseASabatinoGMatteiniPLofreseGMairaGPiniR. An experimental study on minimally occlusive laser-assisted vascular anastomosis in bypass surgery: the importance of temperature monitoring during laser welding procedures. J Biol Regul Homeost Agents2010; 24:307–15.
144.
RuperezMLorenzoOBlanco-ColioLEstebanVEgidoJRuiz-OrtegaM. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation2003; 108:1499–505.
145.
MartinJDenverRBaileyMKrumH. In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling. Clin Exp Pharmacol Physiol2005; 32:697–701.
146.
KureishiYLuoZShoijimaI. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med2000; 6: 1004–10.
147.
Weitz-SchmidtGWelzenbachKBrinkmannV. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med2001; 7:687–92.
148.
RosensonRSTangneyCCCaseyLC. Inhibition of proinflammatory cytokine production by pravastatin, Lancet1999; 353:983–84.
149.
SchonbeckULibbyP. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci2001; 58:4–43.
150.
LutgensEGorelikLDaemenMJ. Requirement for CD 154 in the progression of atherosclerosis. Nat Med1999; 5:1313–16.
151.
FoyTMAruffoABajorathJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol1996; 14:591–617.
152.
BobryshevYVLordRS. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res1998; 37:799–810.
153.
YilmazAReissCTantawiO. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis2004; 172:85–93.
